Stock listing
Renovorx, Inc.
Selected listing: RNXT · NASDAQ · USD · US
Renovorx, Inc. (NASDAQ:RNXT), Health Technology. Latest release Oct 1, 2026: RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform's…
- Ticker
- NASDAQ:RNXT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
About Renovorx, Inc.
Renovorx, Inc. is a public company traded under the ticker RNXT on the American market. The company aims to create value for its stakeholders through strategic initiatives and operational excellence.
Latest news from Renovorx, Inc.
RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer
October 1, 2026
RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer
September 30, 2026
RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th
September 2, 2026
RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer
August 25, 2026
RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
August 21, 2026